[ad_1]
The favorable victory but there are many who at the moment would not be willing to make a Vaccine for COVID-19. This is the result of the poll released by Money.it, in light of the fact that the government seems willing not to make vaccination mandatory for Italians when the serum is ready to be distributed to the population. Speaking of which, it’s not good news that AstraZeneca has failed its tests.
Looking at the poll, which we remember has no scientific value but only indicative since it is not made by sample, compared to a 54% who said he was willing to get vaccinated, there is a 40% which, on the other hand, does not appear to be inclined.
Given that the pandemic shows no signs of loosening, in Italy the situation at the moment seems to be under control but we look very carefully at what will happen after the schools reopen, the issue of vaccines remains central.
At the moment there is no certainty about the opportune moment, given that although both Europe and the United States are willing to simplify the approval process, it is unlikely that the first doses will be distributed to the population. before 2021.
In Italy in recent weeks there has been a lot of talk about rendering the vaccine is mandatory or not anti-Covid: Despite pressure from a part of the majority, Prime Minister Giuseppe Conte wants to take the path of freedom of choice.
A survey on the Covid vaccine
Since the health emergency related to the global spread of coronavirus, all scientists immediately agreed that the crisis will only be overcome when vaccine.
Since that time, dozens of companies, supported by millions of dollars from different world powers, have started their investigations with various tests that at this time would already be in Advanced stage.
As for Italy, much of the hopes were pinned on the brand-name vaccine. Oxford-PomeziaBut now AstraZeneca, which will have to take care of the spread, has announced a halt to evaluate some reactions to the serum.
Then there is the vaccine made by the Spallanzani, which has recently begun the experimentation phase in humans, while in the U.S Moderna is expected to finish phase three of its tests soon.
Regardless of when and how it will be managed, many have pointed out that it is very likely that the Covid vaccine will be distributed to the population while it is still the experimentation phase will not be over.
However, scientists say that this rush will not lead to superficiality in safety assessments, with Europe and the United States ready to speed up the approval process.
Of poll It would be clear that a large part of Italians is not in favor of vaccination against Covid, a percentage that, if real, would make a kind of herd immunity impossible.
